Genetics of Response to Canagliflozin

NCT02891954 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

700

Enrollment

OTHER

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: Canagliflozin

Sponsor

University of Maryland, Baltimore

Collaborators

[object Object]